Aiste Cerbinskaite

Suggest Changes
Learn More
PURPOSE Poly(ADP-ribose) polymerase (PARP) inhibitors selectively target homologous recombination (HR)-defective cells and show good clinical activity in hereditary breast and ovarian cancer(More)
  • 1